Skip to content

A Clinical Trail to Compare the efficacy of transdermal patch of diclofenac and ketoprofen for treatment of post endodontic pain control

COMPARATIVE EVALUATION OF EFFICACY OF DICLOFENAC AND KETOPROFEN ADMINISTERED USING TRANSDERMAL DRUG DELIVERY ROUTE IN MANAGEMENT OF POST ENDODONTIC PAIN: A RANDOMIZED CONTROLLED CLINICAL TRAIL - NOT APPLICABLE

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/054464
Enrollment
30
Registered
2023-06-27
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K040- Pulpitis

Interventions

Intervention1: diflofenac: transdermal patch OF 100 MG -ONCE A DAY FOR TWO DAYS Intervention2: ketoprofen: transdermal patch WITH 30 MG ONCE A DAY FOR 2 DAYS Control Intervention1: diclofenac: oral fo

Sponsors

PANINEEYA INSTITUTE OF DENTAL SCIENCES
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: i) Patients belonging to both sexes between the age group of 18 and 45 years ii) Patients complaining of pain in single-rooted teeth of either jaw and diagnosed as symptomatic irreversible pulpitis. iii) Selected teeth should show intact lamina dura in intraoral periapical radiograph with no periapical radiolucency and absence of anatomical obstacles such as calcifications in the canals with no anticipated procedural difficulties. iv) Patients who give informed consent for the study

Exclusion criteria

Exclusion criteria: i) Patients with hypersensitivity against diclofenac. ii) Patients with a history of allergic reactions such as bronchospasm, shock, urticarial, etc., following the use of diclofenac or other non-steroidal anti-inflammatory drugs (NSAIDs). iii) Patients with active stomach or duodenal ulceration within the last 6 months. iv) Patients undergoing treatment with other NSAIDs or corticosteroids during the study period. v) Patients with a history of systemic diseases such as bronchial asthma, epilepsy, inflammatory bowel disease, severe liver or renal insufficiency, dengue fever, emotional and psychosomatic disorders. vi) Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
RELIEF OF PAIN IN PATIENTTimepoint: AT END OF 4HRS,8 HRS,24 HRS,48 HRS

Secondary

MeasureTime frame
EXPERIENCE OF GASTRIC IRRITATION IN PATIENTSTimepoint: AT END OF 4HRS, 8 HRS, 24 HRS, 48 HRS

Countries

India

Contacts

Public ContactKundana Racha

PANINEEYA MAHAVIDHYALAYA INSTITUTE OF DENTAL SCIENCES,KAMALA NAGAR,DILSHUKNAGAR

drkarthik.basa@gmail.com9985043999

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026